Stephen Bustin

Professor Stephen Bustin is a distinguished academic at Anglia Ruskin University (ARU) within the Faculty of Health, Medicine and Social Care and School of Allied Health and Social Care. As a global authority on quantitative PCR (qPCR), his work bridges molecular medicine and clinical diagnostics, leading the Molecular Diagnostics Unit at ARU's Medical Technology Research Centre (MTRC).

• PhD in Molecular Genetics, Trinity College Dublin
• Editor-in-Chief, Biomolecular Detection and Quantification (Elsevier)

His research spans molecular diagnostics, nucleic acid quantification, and proximity ligation assays. He pioneered the MIQE and digital MIQE guidelines, revolutionizing qPCR/dPCR standardization. His expertise extends to forensic applications, notably advising UK High Court and Washington DC on MMR vaccine-autism litigation.

Recent publications emphasize qPCR optimization (2024), digital PCR standardization (2020), and primer design (2017). Key themes include diagnostic assay development, biomarker quantification, and scientific reproducibility.

• Member, Academy of Europe
• Fellow, Royal Society of Biology
• Editorial leadership in molecular science journals

As an educator, he supervises research on molecular biomarkers for cancer therapy selection and aptamer-based infectious disease diagnostics. His work addresses critical challenges in biomedical research reliability and antibiotic resistance marker detection (e.g., MDR-1).